Matthew Keller
Concepts (499)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1455 | 4.670 |
Why?
| | Polymorphism, Single Nucleotide | 55 | 2026 | 2178 | 4.600 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 101 | 3.980 |
Why?
| | Models, Genetic | 23 | 2025 | 535 | 3.060 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 213 | 3.000 |
Why?
| | Schizophrenia | 16 | 2022 | 430 | 2.930 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2413 | 2.770 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 179 | 1.890 |
Why?
| | Dermatology | 5 | 2025 | 128 | 1.840 |
Why?
| | Homozygote | 11 | 2023 | 201 | 1.760 |
Why?
| | Genome, Human | 13 | 2021 | 429 | 1.680 |
Why?
| | Genetics, Population | 5 | 2022 | 213 | 1.640 |
Why?
| | Phenotype | 32 | 2025 | 3185 | 1.600 |
Why?
| | Genetic Variation | 19 | 2022 | 990 | 1.520 |
Why?
| | Haplotypes | 5 | 2026 | 491 | 1.510 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.350 |
Why?
| | Maternal Inheritance | 2 | 2021 | 15 | 1.340 |
Why?
| | Statistics as Topic | 3 | 2021 | 279 | 1.330 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.190 |
Why?
| | Genomics | 10 | 2026 | 836 | 1.180 |
Why?
| | United Kingdom | 9 | 2025 | 332 | 1.120 |
Why?
| | Twins | 5 | 2021 | 156 | 1.110 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 117 | 1.100 |
Why?
| | Mental Disorders | 12 | 2022 | 1129 | 1.090 |
Why?
| | Humans | 150 | 2026 | 144228 | 1.080 |
Why?
| | Family | 7 | 2024 | 692 | 1.070 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 828 | 1.070 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 107 | 1.060 |
Why?
| | Linkage Disequilibrium | 7 | 2026 | 249 | 1.040 |
Why?
| | Family Characteristics | 2 | 2025 | 199 | 1.010 |
Why?
| | Marriage | 3 | 2025 | 122 | 0.980 |
Why?
| | Genome | 3 | 2018 | 304 | 0.980 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 132 | 0.970 |
Why?
| | Genotype | 14 | 2026 | 1839 | 0.960 |
Why?
| | Academic Success | 2 | 2023 | 32 | 0.960 |
Why?
| | Cognition | 15 | 2022 | 1255 | 0.940 |
Why?
| | Chromosomes | 1 | 2026 | 107 | 0.930 |
Why?
| | Reproduction | 4 | 2022 | 207 | 0.910 |
Why?
| | Smoking | 7 | 2025 | 1557 | 0.900 |
Why?
| | Family Health | 2 | 2024 | 193 | 0.880 |
Why?
| | Software | 3 | 2017 | 692 | 0.870 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 152 | 0.860 |
Why?
| | Environment | 5 | 2017 | 306 | 0.850 |
Why?
| | Spouses | 1 | 2025 | 107 | 0.830 |
Why?
| | Communication Barriers | 2 | 2016 | 123 | 0.820 |
Why?
| | Sexual Partners | 1 | 2025 | 191 | 0.810 |
Why?
| | Informed Consent | 2 | 2016 | 198 | 0.800 |
Why?
| | Depression | 4 | 2022 | 1525 | 0.800 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 18 | 0.790 |
Why?
| | Body Height | 6 | 2025 | 202 | 0.750 |
Why?
| | Algorithms | 4 | 2026 | 1844 | 0.750 |
Why?
| | Biological Evolution | 4 | 2018 | 489 | 0.740 |
Why?
| | Mentors | 2 | 2025 | 215 | 0.730 |
Why?
| | Intelligence | 6 | 2025 | 117 | 0.730 |
Why?
| | Female | 79 | 2026 | 77795 | 0.710 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 223 | 0.700 |
Why?
| | Pedigree | 5 | 2024 | 513 | 0.670 |
Why?
| | Educational Status | 8 | 2024 | 463 | 0.660 |
Why?
| | Male | 67 | 2026 | 71757 | 0.660 |
Why?
| | Computer Simulation | 7 | 2022 | 1033 | 0.650 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.640 |
Why?
| | Research Design | 6 | 2018 | 1122 | 0.610 |
Why?
| | Adult | 51 | 2026 | 40230 | 0.610 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 14 | 0.600 |
Why?
| | Alleles | 10 | 2024 | 883 | 0.600 |
Why?
| | Wearable Electronic Devices | 3 | 2025 | 62 | 0.600 |
Why?
| | Bias | 5 | 2022 | 205 | 0.600 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 673 | 0.560 |
Why?
| | Alcoholism | 6 | 2025 | 814 | 0.560 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 4 | 0.560 |
Why?
| | Hyperhidrosis | 1 | 2018 | 7 | 0.560 |
Why?
| | Fees and Charges | 1 | 2018 | 12 | 0.550 |
Why?
| | Psychological Trauma | 1 | 2019 | 57 | 0.550 |
Why?
| | Botulinum Toxins | 1 | 2018 | 46 | 0.530 |
Why?
| | Tympanoplasty | 1 | 2017 | 8 | 0.530 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 17 | 0.520 |
Why?
| | Auditory Threshold | 1 | 2017 | 50 | 0.510 |
Why?
| | Socioeconomic Factors | 3 | 2019 | 1327 | 0.510 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.510 |
Why?
| | Blast Injuries | 1 | 2017 | 63 | 0.500 |
Why?
| | Drug Eruptions | 1 | 2016 | 28 | 0.500 |
Why?
| | Third-Party Consent | 1 | 2016 | 21 | 0.490 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 72 | 0.490 |
Why?
| | Proxy | 1 | 2016 | 33 | 0.490 |
Why?
| | Psychotic Disorders | 2 | 2016 | 170 | 0.490 |
Why?
| | Skin Neoplasms | 2 | 2014 | 862 | 0.480 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 572 | 0.470 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 877 | 0.460 |
Why?
| | Genetic Loci | 9 | 2022 | 275 | 0.460 |
Why?
| | Creativity | 1 | 2015 | 17 | 0.450 |
Why?
| | Internship and Residency | 2 | 2025 | 1255 | 0.450 |
Why?
| | Nootropic Agents | 3 | 2021 | 30 | 0.440 |
Why?
| | Physician-Patient Relations | 3 | 2016 | 586 | 0.440 |
Why?
| | Body Mass Index | 5 | 2024 | 2446 | 0.430 |
Why?
| | Likelihood Functions | 5 | 2022 | 143 | 0.420 |
Why?
| | Parkinson Disease | 3 | 2025 | 595 | 0.420 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 374 | 0.410 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 4 | 0.410 |
Why?
| | Nevus, Pigmented | 1 | 2014 | 35 | 0.400 |
Why?
| | Deglutition Disorders | 2 | 2025 | 150 | 0.400 |
Why?
| | Middle Aged | 34 | 2026 | 35731 | 0.400 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 128 | 0.400 |
Why?
| | Depressive Disorder | 2 | 2007 | 368 | 0.390 |
Why?
| | Bipolar Disorder | 2 | 2015 | 254 | 0.390 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 32 | 0.390 |
Why?
| | Telemedicine | 1 | 2022 | 944 | 0.380 |
Why?
| | Medication Therapy Management | 1 | 2013 | 72 | 0.380 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 188 | 0.380 |
Why?
| | Fluorouracil | 1 | 2013 | 237 | 0.370 |
Why?
| | Affect | 2 | 2005 | 319 | 0.370 |
Why?
| | Dementia | 1 | 2016 | 298 | 0.370 |
Why?
| | Marijuana Abuse | 1 | 2015 | 213 | 0.360 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.360 |
Why?
| | Inbreeding | 1 | 2011 | 19 | 0.350 |
Why?
| | Gene Frequency | 6 | 2022 | 483 | 0.350 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 322 | 0.340 |
Why?
| | Sex Characteristics | 2 | 2013 | 786 | 0.340 |
Why?
| | Young Adult | 20 | 2026 | 13949 | 0.330 |
Why?
| | Social Environment | 4 | 2019 | 259 | 0.320 |
Why?
| | Genetic Markers | 3 | 2020 | 338 | 0.320 |
Why?
| | Risk Factors | 14 | 2025 | 10641 | 0.320 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 707 | 0.320 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1082 | 0.320 |
Why?
| | Bariatric Surgery | 2 | 2024 | 232 | 0.310 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 100 | 0.310 |
Why?
| | Live Birth | 2 | 2020 | 68 | 0.310 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.310 |
Why?
| | Aged | 18 | 2026 | 25675 | 0.310 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.300 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 30 | 0.300 |
Why?
| | Models, Statistical | 5 | 2018 | 680 | 0.300 |
Why?
| | Life Change Events | 2 | 2007 | 146 | 0.300 |
Why?
| | Fathers | 1 | 2009 | 51 | 0.290 |
Why?
| | Stillbirth | 2 | 2019 | 77 | 0.290 |
Why?
| | Personality | 2 | 2012 | 132 | 0.290 |
Why?
| | Retrospective Studies | 18 | 2026 | 16805 | 0.280 |
Why?
| | Models, Theoretical | 3 | 2021 | 586 | 0.280 |
Why?
| | Dysphonia | 2 | 2018 | 15 | 0.280 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 223 | 0.280 |
Why?
| | Psychiatry | 1 | 2011 | 187 | 0.280 |
Why?
| | Registries | 2 | 2015 | 2248 | 0.280 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2013 | 647 | 0.280 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 32 | 0.280 |
Why?
| | Evolution, Molecular | 2 | 2017 | 513 | 0.280 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 53 | 0.280 |
Why?
| | Adolescent | 27 | 2026 | 22282 | 0.280 |
Why?
| | Psoriasis | 2 | 2021 | 110 | 0.270 |
Why?
| | Genetic Association Studies | 4 | 2019 | 375 | 0.270 |
Why?
| | Inheritance Patterns | 4 | 2021 | 44 | 0.270 |
Why?
| | Parent-Child Relations | 2 | 2021 | 280 | 0.270 |
Why?
| | Inappropriate Prescribing | 2 | 2026 | 63 | 0.260 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 19 | 0.260 |
Why?
| | Chromosomes, Human | 3 | 2018 | 44 | 0.260 |
Why?
| | Computational Biology | 1 | 2011 | 685 | 0.250 |
Why?
| | Chromosome Mapping | 3 | 2015 | 511 | 0.240 |
Why?
| | Pediatric Obesity | 2 | 2024 | 630 | 0.240 |
Why?
| | Facial Injuries | 1 | 2026 | 24 | 0.240 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1328 | 0.230 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3402 | 0.230 |
Why?
| | Pregnancy | 7 | 2025 | 7180 | 0.230 |
Why?
| | Selection, Genetic | 2 | 2012 | 258 | 0.230 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 226 | 0.230 |
Why?
| | Weather | 1 | 2005 | 43 | 0.220 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 6031 | 0.220 |
Why?
| | Positive-Pressure Respiration | 1 | 2026 | 111 | 0.220 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2223 | 0.220 |
Why?
| | Executive Function | 2 | 2022 | 456 | 0.220 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 35 | 0.220 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 63 | 0.220 |
Why?
| | Noninvasive Ventilation | 1 | 2026 | 65 | 0.220 |
Why?
| | Needs Assessment | 2 | 2020 | 400 | 0.220 |
Why?
| | Recombination, Genetic | 2 | 2016 | 202 | 0.210 |
Why?
| | Apolipoproteins E | 1 | 2024 | 92 | 0.200 |
Why?
| | Pregnancy Complications | 2 | 2019 | 593 | 0.200 |
Why?
| | Alcohol Drinking | 2 | 2022 | 831 | 0.200 |
Why?
| | Cognition Disorders | 2 | 2019 | 542 | 0.190 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 12 | 0.190 |
Why?
| | Ureteral Calculi | 1 | 2022 | 16 | 0.190 |
Why?
| | Tobacco Products | 1 | 2024 | 89 | 0.190 |
Why?
| | Parents | 2 | 2022 | 1415 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 44 | 0.190 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 43 | 0.180 |
Why?
| | Lithotripsy | 1 | 2022 | 49 | 0.180 |
Why?
| | Birth Weight | 1 | 2025 | 524 | 0.180 |
Why?
| | Face | 2 | 2013 | 173 | 0.180 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 326 | 0.180 |
Why?
| | Tobacco Use | 1 | 2022 | 64 | 0.180 |
Why?
| | Internationality | 1 | 2022 | 154 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 31 | 0.180 |
Why?
| | Faculty, Medical | 1 | 2025 | 299 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 424 | 0.180 |
Why?
| | Health Care Costs | 2 | 2022 | 418 | 0.180 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.180 |
Why?
| | Mutation, Missense | 2 | 2019 | 342 | 0.170 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 15 | 0.170 |
Why?
| | Respiratory Rate | 1 | 2021 | 23 | 0.170 |
Why?
| | Tibial Fractures | 1 | 2022 | 75 | 0.170 |
Why?
| | Wireless Technology | 1 | 2021 | 18 | 0.170 |
Why?
| | Gastric Bypass | 1 | 2022 | 123 | 0.170 |
Why?
| | Genotyping Techniques | 2 | 2018 | 70 | 0.160 |
Why?
| | Tremor | 2 | 2018 | 98 | 0.160 |
Why?
| | Respiratory Sounds | 1 | 2021 | 106 | 0.160 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.160 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 47 | 0.160 |
Why?
| | Cohort Studies | 7 | 2026 | 5876 | 0.160 |
Why?
| | Inpatients | 2 | 2022 | 529 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2025 | 365 | 0.160 |
Why?
| | Aged, 80 and over | 7 | 2026 | 8154 | 0.160 |
Why?
| | Hysterectomy | 1 | 2021 | 137 | 0.150 |
Why?
| | Analgesics, Opioid | 2 | 2026 | 1135 | 0.150 |
Why?
| | Hospitalization | 5 | 2021 | 2346 | 0.150 |
Why?
| | Mental Health | 2 | 2024 | 778 | 0.150 |
Why?
| | Medicaid | 2 | 2021 | 456 | 0.150 |
Why?
| | Behavior, Addictive | 1 | 2020 | 89 | 0.150 |
Why?
| | Maternal Health | 1 | 2019 | 52 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 5 | 0.150 |
Why?
| | Florida | 4 | 2019 | 115 | 0.150 |
Why?
| | Friends | 1 | 2019 | 58 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 223 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 196 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 30 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 330 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 36 | 0.150 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 35 | 0.150 |
Why?
| | Laryngismus | 1 | 2018 | 11 | 0.140 |
Why?
| | History, 20th Century | 1 | 2020 | 328 | 0.140 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 20 | 0.140 |
Why?
| | Obesity, Morbid | 1 | 2022 | 278 | 0.140 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 128 | 0.140 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 202 | 0.140 |
Why?
| | Chronic Pain | 1 | 2023 | 283 | 0.140 |
Why?
| | Bacterial Toxins | 1 | 2019 | 108 | 0.140 |
Why?
| | Time-to-Treatment | 1 | 2020 | 236 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 132 | 0.140 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 90 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1123 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 82 | 0.140 |
Why?
| | Europe | 2 | 2022 | 411 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 476 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5327 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2930 | 0.140 |
Why?
| | Opioid-Related Disorders | 1 | 2026 | 582 | 0.130 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 187 | 0.130 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 34 | 0.130 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 45 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 386 | 0.130 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 57 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 90 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 289 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 15 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1463 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 843 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 32 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 21 | 0.130 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 553 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 316 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 162 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2017 | 3618 | 0.120 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 380 | 0.120 |
Why?
| | Patient Discharge | 2 | 2022 | 943 | 0.120 |
Why?
| | Parenting | 1 | 2020 | 324 | 0.120 |
Why?
| | Patient Readmission | 1 | 2022 | 725 | 0.120 |
Why?
| | United States | 8 | 2026 | 15641 | 0.120 |
Why?
| | Postpartum Period | 1 | 2019 | 360 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 614 | 0.120 |
Why?
| | Phylogeny | 1 | 2021 | 1012 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 1003 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 618 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2022 | 841 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 146 | 0.120 |
Why?
| | Retina | 1 | 2018 | 323 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 185 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 444 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 175 | 0.120 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.110 |
Why?
| | Ambulatory Care | 1 | 2020 | 598 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 370 | 0.110 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 39 | 0.110 |
Why?
| | Curriculum | 1 | 2022 | 1055 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 17 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1986 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 133 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 452 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 181 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 390 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 517 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 199 | 0.100 |
Why?
| | Comorbidity | 2 | 2019 | 1638 | 0.100 |
Why?
| | Masculinity | 1 | 2013 | 11 | 0.100 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 121 | 0.100 |
Why?
| | Genetic Testing | 1 | 2017 | 478 | 0.100 |
Why?
| | Genetic Fitness | 1 | 2014 | 59 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2024 | 1183 | 0.100 |
Why?
| | Moral Obligations | 1 | 2013 | 15 | 0.100 |
Why?
| | Prescription Drug Diversion | 1 | 2013 | 13 | 0.100 |
Why?
| | Infant, Newborn | 1 | 2025 | 6380 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1150 | 0.100 |
Why?
| | Biopsy, Needle | 1 | 2014 | 184 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 144 | 0.100 |
Why?
| | Asthma | 1 | 2026 | 1916 | 0.100 |
Why?
| | Administration, Topical | 1 | 2013 | 152 | 0.100 |
Why?
| | Liability, Legal | 1 | 2013 | 42 | 0.100 |
Why?
| | Africa | 1 | 2013 | 113 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 404 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 324 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1069 | 0.100 |
Why?
| | Child | 10 | 2026 | 22493 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 431 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 864 | 0.090 |
Why?
| | Adolescent Development | 1 | 2013 | 76 | 0.090 |
Why?
| | Anxiety Disorders | 1 | 2016 | 365 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2019 | 940 | 0.090 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 1003 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2022 | 11501 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2502 | 0.090 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 422 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 177 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 11 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 639 | 0.090 |
Why?
| | Monitoring, Physiologic | 2 | 2025 | 291 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 636 | 0.090 |
Why?
| | Virginia | 2 | 2009 | 55 | 0.080 |
Why?
| | Life Style | 2 | 2021 | 485 | 0.080 |
Why?
| | NF-kappa B | 1 | 2015 | 668 | 0.080 |
Why?
| | Population Density | 1 | 2011 | 101 | 0.080 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 69 | 0.080 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 167 | 0.080 |
Why?
| | Military Personnel | 1 | 2017 | 694 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 204 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 782 | 0.070 |
Why?
| | Sexual Behavior | 1 | 2013 | 490 | 0.070 |
Why?
| | Decision Making | 1 | 2016 | 967 | 0.070 |
Why?
| | International Classification of Diseases | 2 | 2019 | 140 | 0.070 |
Why?
| | Risk | 3 | 2019 | 902 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 494 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2955 | 0.070 |
Why?
| | Child, Preschool | 5 | 2026 | 11656 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 881 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2820 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 249 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 67 | 0.060 |
Why?
| | Personality Inventory | 1 | 2007 | 134 | 0.060 |
Why?
| | Health Status | 2 | 2024 | 821 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 116 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2852 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1309 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 788 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1171 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 974 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1306 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1314 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 68 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 78 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2630 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 526 | 0.060 |
Why?
| | Deglutition | 1 | 2025 | 72 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 1049 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 19 | 0.060 |
Why?
| | Norway | 1 | 2024 | 46 | 0.060 |
Why?
| | Connexin 43 | 1 | 2005 | 36 | 0.050 |
Why?
| | Australia | 1 | 2005 | 286 | 0.050 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2268 | 0.050 |
Why?
| | Social Isolation | 1 | 2005 | 72 | 0.050 |
Why?
| | Connexins | 1 | 2005 | 56 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2024 | 49 | 0.050 |
Why?
| | Mastectomy | 1 | 2025 | 171 | 0.050 |
Why?
| | Propensity Score | 1 | 2026 | 360 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 16 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2026 | 312 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 286 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 139 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 122 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 63 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 291 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 67 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 251 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 600 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 111 | 0.040 |
Why?
| | Hand | 1 | 2022 | 161 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2026 | 978 | 0.040 |
Why?
| | Infant | 3 | 2020 | 9911 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2909 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1514 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 190 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 375 | 0.040 |
Why?
| | Animals | 6 | 2019 | 38231 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 501 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 4120 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 993 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2101 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 20 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 22 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 33 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1858 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 63 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 99 | 0.040 |
Why?
| | New York | 1 | 2019 | 125 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 31 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 27 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 90 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 73 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 54 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 68 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 322 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 543 | 0.040 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 69 | 0.040 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 12 | 0.030 |
Why?
| | Voice Quality | 1 | 2018 | 24 | 0.030 |
Why?
| | Cefotaxime | 1 | 2017 | 3 | 0.030 |
Why?
| | Counseling | 1 | 2021 | 400 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 304 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1640 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 396 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 380 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 135 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 696 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2024 | 616 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 517 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 999 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 254 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 837 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1057 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 45 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 859 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 470 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 441 | 0.030 |
Why?
| | Mice | 3 | 2019 | 18471 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 774 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1110 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1361 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5776 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 378 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1430 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 199 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1509 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 291 | 0.030 |
Why?
| | Finland | 1 | 2014 | 81 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2096 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 113 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 6 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 436 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 531 | 0.020 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 64 | 0.020 |
Why?
| | Sex Factors | 1 | 2019 | 2081 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 64 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 158 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 382 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 333 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 104 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3124 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3295 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 555 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4172 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1836 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 44 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3560 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 91 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 4221 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3620 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1093 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 84 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1902 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4591 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2904 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 272 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4258 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 256 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7081 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 256 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4159 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1125 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1048 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4578 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 2056 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 657 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 9 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 77 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 635 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 126 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 65 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 242 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 890 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 408 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 329 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1058 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5256 | 0.010 |
Why?
| | Pain | 1 | 2005 | 777 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3842 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|